Azienda Ospedaliero - Universitaria di Modena
Modena, 41124, Italy
NCT Number: NCT03747029
Primary hyperparathyroidism (PHPT) and Hypoparathyroidism (HP) are two of the most frequent disorder of Calcium-Phosphorus (Ca-P) metabolism. The Ca/P ratio is an accurate tool to differentiate patients with PHPT from healthy subjects, according to a previous single-centre study. The reliability of this index is based on the fact that serum Ca and P are inversely related together either in healthy subjects or in patients with PHPT and HP.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Modena, 41124, Italy
The aim of this study is to investigate the accuracy and diagnostic value of Ca/P ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism. The definition of a valid cut-off of serum Ca/P ratio for patients with these disorders will be of help especially in those patients with apparently normal biochemical profile, but suggestive for primary hyperparathyroidism and hypoparathyroidism.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
for both cases and controls will be:
No intervention is provided
Time frame: Assessed only once at the diagnosis (from January 2005 to January 2018)
Calculated formula (serum calcium to serum phosphorus ratio)
Time frame: Assessed only once at the diagnosis (from January 2005 to January 2018)
From blood sample - Unit of measurement: mg/dl
Time frame: Assessed only once at the diagnosis (from January 2005 to January 2018)
From blood sample - Unit of measurement: mg/dl
Time frame: Assessed only once at the diagnosis (from January 2005 to January 2018)
From blood sample - Unit of measurement: pg/ml
Azienda Ospedaliero-Universitaria di Modena
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04019379
Avitaminosis, Bone Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT03603444
Phosphorus and Calcium Disorders
Modena, Italy
View Trial DetailsNCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT04009291
Endocrine System Diseases, Hypoparathyroidism
Chicago, Illinois, United States
View Trial Details